Key result
Preclinical large animal models highlight targeted delivery, neural regulation, and cardiac remodeling for cardiovascular surgery.
Why the study?
Current treatments for cardiovascular diseases have deficiencies, prompting the development and testing of innovative surgical therapies in large animal models.
This review summarizes recent preclinical studies on surgical therapies for cardiovascular diseases using large animal models, offering new perspectives for clinical translation.
Findings from large-animal models remain hypothesis-generating for surgical cardiovascular therapies; clinical trials needed before translation.
Cardiovascular disease is the most common cause of death worldwide, resulting in millions of deaths annually. Currently, there are still some deficiencies in the treatment of cardiovascular diseases. Innovative surgical treatments are currently being developed and tested in response to this situation. Large animal models, which are similar to humans in terms of anatomy, physiology, and genetics, play a crucial role in connecting basic research and clinical applications. This article reviews recent preclinical studies and the latest clinical advancements in cardiovascular disease based on large animal models, with a focus on targeted delivery, neural regulation, cardiac remodeling, and hemodynamic regulation. It provides new perspectives and ideas for clinical translation and offers new methods for clinical treatment.
No takes yet. Share an insight, caveat, or question.
Li et al. (2024) conducted a review in Cardiovascular diseases. Preclinical surgical therapy was evaluated. Recent preclinical studies using large animal models provide new perspectives for surgical treatment of cardiovascular diseases, focusing on targeted delivery, neural regulation, and cardiac remodeling.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: